Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2

Ítems similars

• A Protective Role of Locally Administered Immunostimulatory CpG Oligodeoxynucleotide in a Mouse Model of Genital Herpes Infection
  per: Harandi, Ali M., et al.
  Publicat: (2003)
• Immunopharmacology of CpG Oligodeoxynucleotides and Ribavirin
  per: Vollmer, Jörg, et al.
  Publicat: (2004)
• CD8(+) T-Cell-Mediated Cross-Clade Protection in the Genital Tract following Intranasal Immunization with Inactivated Human Immunodeficiency Virus Antigen Plus CpG Oligodeoxynucleotides
  per: Jiang, Janina Q., et al.
  Publicat: (2005)
• Replication-Competent Controlled Herpes Simplex Virus
  per: Bloom, David C., et al.
  Publicat: (2015)
• Mucosal Administration of CpG Oligodeoxynucleotide Elicits Strong CC and CXC Chemokine Responses in the Vagina and Serves as a Potent Th1-Tilting Adjuvant for Recombinant gD2 Protein Vaccination against Genital Herpes
  per: Tengvall, Sara, et al.
  Publicat: (2006)